Jul 11, 20233 min readHealthDupixent® (dupilumab) is now approved in India for the treatment of adults with moderate-to-severe aSanofi Healthcare India Pvt. Ltd. today announced that it has received marketing authorization for Dupixent® (dupilumab), the first...